Goodwin

Katerina Stavrianidis

Deals
3
Latest
Apr 2026
Most deals in
Biotech

Firm

  • Goodwin Law firm · 2026 · 3 deals
Deals by year
Katerina Stavrianidis: deals by year0320252026 YTD: 2 M&A2026 YTD: 1 Equity raisings32026 YTDM&AEquity raisings

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Katerina Stavrianidis was named on, most recent first
Apr 2026 Obsidian Therapeutics ––PlacementLegal adviser to Obsidian TherapeuticsCompleted350.0Biotech+2Obsidian Therapeutics placement
Apr 2026 Obsidian Therapeutics –Galera TherapeuticsMergerLegal adviser to Obsidian TherapeuticsCompleted413.5Biotech+2Galera Therapeutics and Obsidian Therapeutics merger
Mar 2026 Ouro Medicines –GileadAcquisitionLegal adviser to Ouro Medicines (target)Announced1,675.0Biotech+1Gilead acquisition of Ouro Medicines

Deals where Katerina Stavrianidis is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.